Dr. Heyman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Gilman Dr
La Jolla, CA 92093
Education & Training
Duke University HospitalResidency, Internal Medicine, 2011 - 2014
University of Virginia School of MedicineClass of 2011- Duke University HospitalFellowship, Hematology and Medical Oncology
Certifications & Licensure
CA State Medical License 2018 - 2026
NC State Medical License 2011 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 162 citationsHedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitmentAmy J. Petty, Ang Li, Xinyi Wang, Rui Dai, Benjamin Heyman
The Journal of Clinical Investigation. 2019-12-02 - 24 citationsChimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle Cancer.Amy J. Petty, Benjamin Heyman, Yiping Yang
Cancers. 2020-03-31 - 38 citationsMechanisms of heparanase inhibitors in cancer therapy.Benjamin Heyman, Yiping Yang
Experimental Hematology. 2016-11-01
Press Mentions
Dr. Heyman on the Use of Maintenance Rituximab in Follicular LymphomaFebruary 28th, 2020- Optimal Treatment Selection Needed in Advanced Follicular LymphomaFebruary 25th, 2020
- Dr. Heyman on Frontline Treatment Options in Follicular LymphomaFebruary 20th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
